[ Neuronetics raises $15M in Series G ]
Neuronetics has raised $15 million in Series G funding.
Founded in 2003, Neuronetics is a privately held medical device company focused on developing non-invasive therapies for psychiatric and neurological disorders using MRI-strength magnetic field pulses.
The company intends to use the funds to continue to expand operations.
|Founder / CEO||Chris Thatcher|
|Accuitive Medical Ventures|
|Investor Growth Capital|
|KBL Healthcare Ventures|
|New Leaf Venture Partners|
|Pfizer Venture Investments|
|Three Arch Partners|
|Previous Investors||same as above except Ascension Ventures, Industry Ventures|
|Partisan Management Group|